Innovation. Investment. Impact.
Empowering life science innovators to reach their next breakthrough.
We help life science companies raise capital, execute transactions, and accelerate growth — creating lasting value together.
Catalyzing growth
Aurelia Partners is a dedicated financial advisor to the life sciences sector. Founded by professionals with backgrounds in venture capital, investment banking, and healthcare equity research, we combine deep expertise with a proven track record to bring clarity to complex transactions.
We help life science innovators we deeply believe in raise capital, execute strategic deals, and accelerate growth. Our unparalleled network of leading institutional investors, venture funds, and family offices connects breakthrough companies with the right capital at the right time—driving successful outcomes.
Independent and focused, we provide high-quality advice and support that builds long-term value and helps clients turn scientific innovation into lasting impact.
Meet the Team
-
MSc Pharm, MBA
25+ years of life science industry experience. Co-founder and CEO of Wilson Therapeutics (acquired by Alexion for $855m). Co-founder of Purpose Pharma and former Partner at HealthCap, one of Europe’s leading life science venture capital firms. Operational experience as CEO of a publicly listed company and as board member in multiple biotech ventures. Proven track record in building and scaling companies, capital raising, and guiding organizations through IPOs, M&A and partnerships.
-
MBBS/BSc Pharm, MPhil
Former Pharma Analyst and Head of Healthcare Equity Research at ABG Sundal Collier. Medical degree and BSc in Pharmacology from Imperial College London, followed by clinical practice at University College Hospital, London. MPhil in Bioscience Enterprise from Queens’ College, Cambridge. Combines medical and scientific expertise with capital markets experience, including multiple life science transactions.
-
MSc BA & Economics
30+ years experience in life science venture capital and investment banking. Co-founder of Purpose Pharma and former Partner at HealthCap. Co-founder of investment banking boutique Hjalmarsson & Gunterberg and former Head of the Healthcare Group at Aros Securities. Extensive track record in financings, strategic transactions, M&A and shareholder/corporate governance from public and private companies in Europe and the US.
-
MSc Accounting & Finance
Former MedTech Equity Research Analyst at leading Nordic investment banks, ranked #1 in the Institutional Investor Survey (Prospera). 8+ years of capital markets experience, including experience as a mutual fund analyst, with a strong Nordic and international investor network.
Transactions
-
Moleculent
Private placement totalling USD 26m (2024)
-
Guard Therapeutics
Directed share issue totalling USD 12m (2023)
Directed share issue + repair issue totalling USD 7m (2024)
-
Twiceme Technology
Private placement, undisclosed amount (2022)
Contact us
Contact
team@aurelia.partners
+46 73 337 45 01
Address
Grev Turegatan 13b
114 46 Stockholm Sweden